Hers Review: Every Price on the Page Is Medication Only

Two charges every month, and only one of them is on the price you see. The Weight Loss Membership is $39 for the first month and $149 a month after that. Medication is billed separately on its own monthly subscription. So the Wegovy Pen is $39 + $199 = $238 to start, then $149 + $199 = $348. The Wegovy Pill is $188, then $298. The Zepbound vial is $338, then $448. The medication half never changes; the membership half goes up 282% between month one and month two.

No, twice over. First, $199 is medication only — Hers' own dagger says "Price includes medication only, if prescribed. An active Hers Weight Loss Membership is required." Second, $199 is a floor, not a price: the card reads "Starts at $199/mo," and the FAQ says "Pricing may vary by dosage." Hers offers the 7.2 mg high dose and does not publish what it costs. The $348 walk-away figure on this page is the all-in cost at the starting dose, which is the most a reader can verify from what Hers publishes.

On the Wegovy Pen, $238 for month one plus eleven months at $348 is $4,066. On the Wegovy Pill it is $188 plus eleven at $298, or $3,466. On the Zepbound vial, $338 plus eleven at $448 is $5,266. Those are starting-dose figures — if the dose price rises with the dose, and Hers implies it does, the real total is higher and there is no published number to compute it from. For comparison at the same branded drug, a first year of Zepbound through Ro is $6,916.

Both figures are on forhers.com/weight-loss at the same time. "Zepbound® Vial" and "Zepbound® KwikPen®" are each "From $299/mo" and carry the medication-only dagger. A separate card reading just "Zepbound®" is $1,899/mo, carries the same dagger, has no product page and no "From." The $1,899 sits at roughly the drug's cash list price, which suggests it is the retail-pharmacy route rather than the self-pay programme — but Hers does not say that anywhere, and a reader clicking the wrong card pays $1,600 a month more.

It will not say. Hers' weight-loss FAQ states that "GLP-1s are not yet available in all 50 states" and that it is "working to expand our offering as soon as possible," and publishes no list of the states that are excluded. Nothing on forhers.com, in its terms, or in its support centre names them. The only way to find out is to start the intake and reach the state question. Hers also says the free smart scale is "not available in 50 states," which is a separate limitation on a separate benefit.

No. The FDA warning letter of September 9, 2025 concerned two marketing claims about compounded semaglutide on forhers.com. As of August 2026 the weight-loss line-up is entirely FDA-approved branded product — Wegovy in pill and pen, Zepbound in vial and KwikPen, Ozempic, Mounjaro, and Foundayo — with no compounded GLP-1 offered at any price. That letter alleges misbranding under FDCA 502(a) and 502(bb), which is a marketing and labelling matter; it makes no product-quality finding, and a warning letter is a public regulatory communication rather than a finding of illegal activity.

You can cancel in the app, under "My Subscriptions" online, or by calling 1-800-368-0038, and cancelling a medication plan does not cancel the membership. What you have already paid mostly stays paid: Hers' terms say the first month's membership fee is non-refundable and that it does not refund partially used subscription periods, though it may make exceptions at its own discretion. If you fill through Gifthealth rather than a Hers pharmacy, its terms are explicit that cancellations, billing questions and refunds for that medication are handled directly with Gifthealth, not with Hers.